Family Medicine — Management of Prevalent Chronic Pathologies in Primary Care

Family Medicine · Clinical Specialties

How it begins

Un compendio exhaustivo y estructurado bajo los más altos estándares científicos para el abordaje de pacientes multimórbidos en el ámbito de la Atención Primaria de Salud (APS). Se integran las últimas recomendaciones internacionales de sociedades de referencia (ESC, ADA, KDIGO, GOLD, GINA) con un enfoque en la continuidad asistencial y la personalización terapéutica.

What it covers

1. Primary Care and Multimorbidity
2. · The Chronic Care Model
3. · The Prescription Cascade and Iatrogenesis
4. Essential Arterial Hypertension (HTN)
5. · Pathophysiology of Essential HTN
6. · Clinical Diagnosis and Ambulatory Monitoring
7. · Cardiovascular Risk Stratification (SCORE2 Risk)
8. · Initial Pharmacological Treatment and Escalation
9. Diabetes Mellitus Type 2 (DM2)
10. · Pathophysiology: The Ominous Octet (DeFronzo)
11. · DM2 Diagnosis Algorithm
12. · Personalized Pharmacological Treatment
13. Dyslipidemia and Cardiovascular Risk (CVR)
14. · Physiopathological Classification of Dyslipidemia
15. · Stratification of LDL-c Objectives (ESC/EAS Guidelines 2021/2024)
16. · Pharmacological Intervention Algorithm
17. Chronic Ischemic Heart Disease (Chronic Coronary Syndrome)
18. · Pathophysiology of Chronic Coronary Syndrome
19. · Diagnostic and Clinical Stratification
20. · Comprehensive Medical Treatment of SCC (ESC 2024)
21. Chronic Heart Failure (HF)
22. · Classification Based on Ejection Fraction (ESC 2021/2023)
23. · HF Diagnosis Algorithm in Primary Care
24. · HFrEF Treatment: The Four Fundamental Pillars
25. Chronic Obstructive Pulmonary Disease (COPD)
26. · Pathophysiology of Lung Damage in COPD
27. · Standardized Spirometric Diagnosis
28. · Multidimensional Stratification and GOLD Classification 2024
29. Bronchial Asthma in Adults
30. · Pathophysiology of Asthmatic Inflammation
31. · Clinical and Functional Diagnosis
32. · Stepped Therapeutic Strategy (GINA Track 1)
33. Chronic Kidney Disease (CKD)
34. · KDIGO Classification and Staging
35. · Active Nephroprotection Strategies
36. Obesity and Metabolic Syndrome
37. · Pathophysiology of Adiposopathy (Diseased Fat)
38. · Metabolic Syndrome: Harmonized Consensus Criteria
39. · Advanced Medical Treatment of Obesity
40. Osteoporosis and Degenerative Osteoarticular Pathology
41. · Pathophysiology of Bone Remodeling in Osteoporosis
42. · Fracture Risk Stratification with FRAX
43. · Pharmacological Treatment of Osteoporosis
44. · Management of Osteoarthritis (Osteoarthritis) in Primary Care
45. Depression and Anxiety in Primary Care
46. · Pathophysiology: The Monoaminergic and Neuroplastic Hypothesis
47. · Screening and Clinical Evaluation Tools
48. · Pharmacological Treatment and Psychotherapeutic Approach
49. Cognitive Impairment and Dementia
50. · Pathophysiology of the Main Types of Dementia
51. · Screening Tools in Consultation
52. · Medical Treatment and Management of Behavioral Symptoms (SPCD)
53. Polypharmacy, Appropriate Prescription and Deprescription
54. · Inadequate Prescription Criteria (Beers and STOPP/START)
55. · Practical Methodology for Deprescribing in Consultation